2025 Dry Eye Medication Market Outlook: Opportunities, Growth Trends, and Strategic Analysis
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Latest Market Insights for the Dry Eye Medication Industry?
The market size of contract development and manufacturing organizations (CDMO) for topical drugs has seen quick expansion in the recent past. The market, currently valued at $52.9 billion in 2024, is forecasted to reach $61.16 billion in 2025, with a compound annual growth rate (CAGR) of 15.6%. The significant growth observed during the historic period is ascribable to the widespread occurrence of chronic diseases, advancements in drug delivery technologies, affordable outsourcing, regulatory requirements, and expansion in the dermatology and cosmetics sector.
The market for contract development and manufacturing organizations (CDMO) specializing in topical drugs is projected to experience a significant growth spurt in the upcoming years. It’s predicted to expand to “$107.61 billion by 2029, growing at a compound annual growth rate (CAGR) of 15.2%.” This anticipated surge during the forecast period can be linked to factors like personalized medicine development, expansion in biologics, increased R&D funding, growing prevalence of skin disorders, and advanced manufacturing methods. The forecast period also sees trends such as rising demands for innovative drug formulations, drug delivery technology advancements, increased funding in dermatology research, a boom in pharmaceutical company outsourcing, an emphasis on personalized medicine, strict regulatory demands necessitating specialized knowledge, and an increasing consumer tendency to opt for over-the-counter (OTC) skincare items.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15942&type=smp
What Forces Are Driving The Growth Of The Dry Eye Medication Industry?
The surge in dry eye disease cases is increasing demands for treatment options. Age, vitamin A deficiency, lens use, eye surgery, exposure to harsh environments such as dry wind or smoke, and long periods of screen time can escalate the likelihood of the condition. As per the American Academy of Ophthalmology, almost 3.2 million women and 1.68 million men above the age of 50 suffer from dry eye syndrome in the USA. Similarly, the Indian Journal of Ophthalmology disclosed that there’s a 32% incidence of dry eye disease in North India. This growing incidence of the ailment is expected to fuel the demand for its treatment, thus boosting the dry eye medication market’s expansion.
The topical drugs contract development and manufacturing organization (cdmo) market covered in this report is segmented –
1) By Product Type: Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products
2) By Service Type: Contract Development, Contract Manufacturing
3) By Therapeutic Area: Dermatology, Pain Management, Wound Care, Ophthalmology, Other Therapeutic Areas
4) By End-Use: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses
Subsegments:
1) By Semi-Solid Formulations: Creams, Ointments, Gels, Pastes
2) By Liquid Formulations Drugs: Solutions, Suspensions, Emulsions, Lotions
3) By Solid Formulations: Powders, Tablets
4) By Transdermal Products: Patches
What Long-Term Trends Are Likely To Affect The Dry Eye Medication Market?
Leading corporations in the topical drugs contract development and manufacturing organization (CDMO) market are prioritizing the creation of cutting-edge production facilities to maintain their market standing. These cutting-edge facilities are unique manufacturing sites fitted with the newest technology and sophisticated procedures designed specifically for the fabrication and development of topical pharmaceutical products. For example, in November 2023, SOHM Inc., an American pharmaceutical firm, introduced a CDMO GMP manufacturing facility. This new facility in Carlsbad will provide abundant space for manufacturing topical products and support SOHM’s operations, with an allocated 2,500 square feet for storing finished products. In its initial phase, it is designed to produce 500 gallons (1,892 liters) of topicals daily. By the close of Q1 2024 or commencement of Q2 2024, the facility projects to extend its production capabilities to include soft-gel suppositories.
Who Are The Primary Players Operating Across The Global Dry Eye Medication Market?
Major companies operating in the topical drugs contract development and manufacturing organization (CDMO) market are Evonik Industries AG, Eurofins Scientific SE, SGS SA, The Lubrizol Corporation, Lonza Group AG, Catalent Inc., Bora Pharmaceuticals Co. Ltd., Recipharm AB, Pierre Fabre S.A., Piramal Pharma Solutions, Cambrex Corporation, LTS Lohmann Therapie-Systeme AG, PCI Pharma Services, Famar S.A., Contract Pharmaceuticals Limited, UPM Pharmaceuticals Inc., CoreRx Inc., Halo Pharmaceutical Inc., Tapemark Company, Groupe PARIMA Inc., MedPharm Ltd., Tergus Pharma LLC, Dow Development Laboratories LLC, NextPharma Technologies Holding Limited, Tedor Pharma Inc.
Which Region Offers The Most Growth Potential For The Dry Eye Medication Market Through 2029?
Asia-Pacific was the largest region in the topical drugs contract development and manufacturing organization (CDMO) market in 2024. The regions covered in the topical drugs contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=15942&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
